MedPath

黑龙江省七台河制药厂

Ownership
-
Established
1993-05-14
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

14

NMPA:14

Drug Approvals

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H20227039
Approval Date
Mar 24, 2022
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H20103479
Approval Date
Nov 10, 2021
NMPA

Sodium Chloride Injection

Product Name
氯化钠注射液
Approval Number
国药准字H20217079
Approval Date
Sep 14, 2021
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H20123232
Approval Date
Oct 22, 2020
NMPA

Metronidazole and Glucose Injection

Product Name
甲硝唑葡萄糖注射液
Approval Number
国药准字H23020519
Approval Date
Oct 22, 2020
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H23020516
Approval Date
Oct 22, 2020
NMPA

Sodium Chloride Injection

Product Name
氯化钠注射液
Approval Number
国药准字H23020520
Approval Date
Oct 22, 2020
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H20143146
Approval Date
Oct 22, 2020
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H23020517
Approval Date
Oct 22, 2020
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H20046091
Approval Date
Oct 22, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.